Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1051-1060 of 1,873) with videos related to

Pageof 188
Sort By:
European Journal of Heart Failure|September 1, 2024
Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON-HF trialHenri Lu, Brian L Claggett, Milton Packer, et al.
Nature Medicine|May 10, 2026
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trialJohann Bauersachs, Scott D Solomon, Stefan D Anker, et al.
American Heart Journal|November 6, 2024
Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HFSatoshi Shoji, Derek D Cyr, Adrian F Hernandez, et al.
JACC. Heart Failure|December 14, 2020
Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without DiabetesMuhammad Shahzeb Khan, G Michael Felker, Ileana L Piña, et al.
ESC Heart Failure|January 13, 2021
Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trialCorrado De Marco, Brian L Claggett, Simon de Denus, et al.
Journal of the American College of Cardiology|November 5, 2013
Impaired systolic function by strain imaging in heart failure with preserved ejection fractionElisabeth Kraigher-Krainer, Amil M Shah, Deepak K Gupta, et al.
American Heart Journal|February 23, 2021
Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trialsMuhammad Shahzeb Khan, Soren Lund Kristensen, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|April 30, 2021
Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African AmericansMasatoshi Minamisawa, Riccardo M Inciardi, Brian Claggett, et al.
European Heart Journal. Cardiovascular Imaging|April 20, 2023
Link between myocardial deformation phenotyping using longitudinal and circumferential strain and risk of incident heart failure and cardiovascular deathKristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Niklas Dyrby Johansen, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|March 17, 2000
Reconciling users' needs and formal requirements: issues in developing a reusable ontology for medicineA L Rector, P E Zanstra, W D Solomon, et al.
Pageof 188

Showing results (1051-1060 of 1,873) with videos related to

Sort By:
Pageof 188
European Journal of Heart Failure|September 1, 2024
Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON-HF trialHenri Lu, Brian L Claggett, Milton Packer, et al.
Nature Medicine|May 10, 2026
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trialJohann Bauersachs, Scott D Solomon, Stefan D Anker, et al.
American Heart Journal|November 6, 2024
Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HFSatoshi Shoji, Derek D Cyr, Adrian F Hernandez, et al.
JACC. Heart Failure|December 14, 2020
Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without DiabetesMuhammad Shahzeb Khan, G Michael Felker, Ileana L Piña, et al.
ESC Heart Failure|January 13, 2021
Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trialCorrado De Marco, Brian L Claggett, Simon de Denus, et al.
Journal of the American College of Cardiology|November 5, 2013
Impaired systolic function by strain imaging in heart failure with preserved ejection fractionElisabeth Kraigher-Krainer, Amil M Shah, Deepak K Gupta, et al.
American Heart Journal|February 23, 2021
Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trialsMuhammad Shahzeb Khan, Soren Lund Kristensen, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|April 30, 2021
Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African AmericansMasatoshi Minamisawa, Riccardo M Inciardi, Brian Claggett, et al.
European Heart Journal. Cardiovascular Imaging|April 20, 2023
Link between myocardial deformation phenotyping using longitudinal and circumferential strain and risk of incident heart failure and cardiovascular deathKristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Niklas Dyrby Johansen, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|March 17, 2000
Reconciling users' needs and formal requirements: issues in developing a reusable ontology for medicineA L Rector, P E Zanstra, W D Solomon, et al.
Pageof 188